Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2011

Open Access 01-12-2011 | Research

CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar

Authors: NiNi Tun, Nikolas London, Moe Kyaw Kyaw, Frank Smithuis, Nathan Ford, Todd Margolis, W Lawrence Drew, Susan Lewallen, David Heiden

Published in: Journal of the International AIDS Society | Issue 1/2011

Login to get access

Abstract

Background

Cytomegalovirus retinitis is a neglected disease in resource-poor settings, in part because of the perceived complexity of care and because ophthalmologists are rarely accessible. In this paper, we describe a pilot programme of CMV retinitis management by non-ophthalmologists. The programme consists of systematic screening of all high-risk patients (CD4 <100 cells/mm3) by AIDS clinicians using indirect ophthalmoscopy, and treatment of all patients with active retinitis by intravitreal injection of ganciclovir. Prior to this programme, CMV retinitis was not routinely examined for, or treated, in Myanmar.

Methods

This is a retrospective descriptive study. Between November 2006 and July 2009, 17 primary care AIDS clinicians were trained in indirect ophthalmoscopy and diagnosis of CMV retinitis; eight were also trained in intravitreal injection. Evaluation of training by a variety of methods documented high clinical competence. Systematic screening of all high-risk patients (CD4 <100 cells/mm3) was carried out at five separate AIDS clinics throughout Myanmar.

Results

A total of 891 new patients (1782 eyes) were screened in the primary area (Yangon); the majority of patients were male (64.3%), median age was 32 years, and median CD4 cell count was 38 cells/mm3. CMV retinitis was diagnosed in 24% (211/891) of these patients. Bilateral disease was present in 36% of patients. Patients with active retinitis were treated with weekly intravitreal injection of ganciclovir, with patients typically receiving five to seven injections per eye. A total of 1296 injections were administered.

Conclusions

A strategy of management of CMV retinitis at the primary care level is feasible in resource-poor settings. With appropriate training and support, CMV retinitis can be diagnosed and treated by AIDS clinicians (non-ophthalmologists), just like other major opportunistic infections.
Literature
1.
go back to reference Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL: Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007,4(12):e334.PubMedCrossRef Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL: Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007,4(12):e334.PubMedCrossRef
2.
go back to reference Essential Prevention and Care Interventions for Adults and Adolescents Living with HIV in Resource-Limited Settings In HIV/AIDS Programme: Strengthening health services to fight HIV/AIDS. Geneva: World Health Organization Department of HIV/AIDS; 2008:1–110. Essential Prevention and Care Interventions for Adults and Adolescents Living with HIV in Resource-Limited Settings In HIV/AIDS Programme: Strengthening health services to fight HIV/AIDS. Geneva: World Health Organization Department of HIV/AIDS; 2008:1–110.
3.
go back to reference Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H: Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009,58(RR-4):1–207. quiz CE201–204 Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H: Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009,58(RR-4):1–207. quiz CE201–204
4.
go back to reference Pathanapitoon K, Ausayakhun S, Kunavisarut P, Wattananikorn S, Leeungurastien T, Yodprom R, Narongjunchai D, Rothova A: Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Retina 2007,27(5):635–640.PubMedCrossRef Pathanapitoon K, Ausayakhun S, Kunavisarut P, Wattananikorn S, Leeungurastien T, Yodprom R, Narongjunchai D, Rothova A: Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Retina 2007,27(5):635–640.PubMedCrossRef
5.
go back to reference Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S: Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect 2007,55(5):464–469.PubMedCrossRef Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S: Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect 2007,55(5):464–469.PubMedCrossRef
6.
go back to reference Micol R, Buchy P, Guerrier G, Duong V, Ferradini L, Dousset JP, Guerin PJ, Balkan S, Galimand J, Chanroeun H, Lortholary O, Rouzioux C, Fontanet A, Leruez-Ville M: Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004–2007). J Acquir Immune Defic Syndr 2009,51(4):486–491.PubMedCrossRef Micol R, Buchy P, Guerrier G, Duong V, Ferradini L, Dousset JP, Guerin PJ, Balkan S, Galimand J, Chanroeun H, Lortholary O, Rouzioux C, Fontanet A, Leruez-Ville M: Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004–2007). J Acquir Immune Defic Syndr 2009,51(4):486–491.PubMedCrossRef
7.
go back to reference Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D: Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 2003,121(1):99–107.PubMed Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D: Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 2003,121(1):99–107.PubMed
8.
go back to reference Spector SA, Weingeist T, Pollard RB, Dieterich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ, et al.: A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis 1993,168(3):557–563.PubMedCrossRef Spector SA, Weingeist T, Pollard RB, Dieterich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ, et al.: A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis 1993,168(3):557–563.PubMedCrossRef
9.
go back to reference Yust I, Fox Z, Burke M, Johnson A, Turner D, Mocroft A, Katlama C, Ledergerber B, Reiss P, Kirk O: Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994–2001. Eur J Clin Microbiol Infect Dis 2004,23(7):550–559.PubMedCrossRef Yust I, Fox Z, Burke M, Johnson A, Turner D, Mocroft A, Katlama C, Ledergerber B, Reiss P, Kirk O: Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994–2001. Eur J Clin Microbiol Infect Dis 2004,23(7):550–559.PubMedCrossRef
10.
go back to reference Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, Nyirenda ST, Binkin NJ, Lucas SB: Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Int J Tuberc Lung Dis 2002,6(1):55–63.PubMed Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, Nyirenda ST, Binkin NJ, Lucas SB: Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Int J Tuberc Lung Dis 2002,6(1):55–63.PubMed
11.
go back to reference Pecorella I, Ciardi A, Credendino A, Marasco A, Di Tondo U, Scaravilli F: Ocular, cerebral and systemic interrelationships of cytomegalovirus infection in a post-mortem study of AIDS patients. Eye (Lond) 1999,13(Pt 6):781–785.CrossRef Pecorella I, Ciardi A, Credendino A, Marasco A, Di Tondo U, Scaravilli F: Ocular, cerebral and systemic interrelationships of cytomegalovirus infection in a post-mortem study of AIDS patients. Eye (Lond) 1999,13(Pt 6):781–785.CrossRef
13.
go back to reference WHO/UNAIDS/UNICEF: Epidemiological Fact Sheet on HIV and AIDS: Core Data on Epidemiology and Response, Myanmar. Geneva: UNAIDS/WHO; 2008. WHO/UNAIDS/UNICEF: Epidemiological Fact Sheet on HIV and AIDS: Core Data on Epidemiology and Response, Myanmar. Geneva: UNAIDS/WHO; 2008.
14.
go back to reference Drew WL, Erlich KS: Management of virus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). In Global HIV/AIDS medicine. Edited by: Volberding P, Sande M, Lange J, Greene W, Gallant J. New York: Elsevier; 2007:437–461. Drew WL, Erlich KS: Management of virus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). In Global HIV/AIDS medicine. Edited by: Volberding P, Sande M, Lange J, Greene W, Gallant J. New York: Elsevier; 2007:437–461.
15.
go back to reference Jacobson MA: Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1997,337(2):105–114.PubMedCrossRef Jacobson MA: Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1997,337(2):105–114.PubMedCrossRef
16.
go back to reference Binquet C, Saillour F, Bernard N, Rougier MB, Leger F, Bonnal F, Dabis F: Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986–1997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Eur J Epidemiol 2000,16(5):425–432.PubMedCrossRef Binquet C, Saillour F, Bernard N, Rougier MB, Leger F, Bonnal F, Dabis F: Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986–1997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Eur J Epidemiol 2000,16(5):425–432.PubMedCrossRef
17.
go back to reference Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J: Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis 2003,37(10):1365–1373.PubMedCrossRef Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J: Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis 2003,37(10):1365–1373.PubMedCrossRef
18.
go back to reference Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ: A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002,346(15):1119–1126.PubMedCrossRef Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ: A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002,346(15):1119–1126.PubMedCrossRef
Metadata
Title
CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar
Authors
NiNi Tun
Nikolas London
Moe Kyaw Kyaw
Frank Smithuis
Nathan Ford
Todd Margolis
W Lawrence Drew
Susan Lewallen
David Heiden
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2011
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-14-41

Other articles of this Issue 1/2011

Journal of the International AIDS Society 1/2011 Go to the issue